文献速递临床试验与 GCP

急诊科氯胺酮快速控制激越(RACKED):随机对照试验方案

Rapid agitation control with ketamine in the emergency department (RACKED): a randomized controlled trial protocol.
PubMed 文献 · Trials · 2018-11-26

这是一项前瞻性随机对照试验方案,计划纳入约184例因精神运动性激越和暴力行为就诊急诊科的患者,比较5 mg/kg肌注氯胺酮与5 mg肌注咪达唑仑联合5 mg肌注氟哌啶醇的疗效,主要结局为用RASS评估达到充分行为控制所需时间(分钟)。

要点

  • 比较肌注氯胺酮与肌注咪达唑仑联合氟哌啶醇控制急诊激越的随机对照试验方案
  • 主要结局为RASS评估达到充分行为控制所需时间
  • 计划纳入约184例患者,第3天进行安全性随访

核心结论

  • 该方案旨在验证肌注氯胺酮是否比肌注咪达唑仑联合氟哌啶醇更快速安全地控制急诊科精神运动性激越和暴力行为。

研究设计与样本

  • 前瞻性、平行、随机对照试验,计划纳入约184例急诊科精神运动性激越和暴力行为患者,等比随机分入两个研究组。
  • 干预组为5 mg/kg肌注氯胺酮,对照组为5 mg肌注咪达唑仑联合5 mg肌注氟哌啶醇。
  • 研究期间进行一次给药和评估访视,第3天进行安全性随访。

关键数值与推荐

  • 主要目标为比较肌注氯胺酮与肌注咪达唑仑联合氟哌啶醇达到充分行为控制所需时间(分钟),以RASS评估。
  • 氯胺酮剂量为5 mg/kg肌注;咪达唑仑5 mg肌注联合氟哌啶醇5 mg肌注。
  • 计划纳入约184例患者,等比随机分配至两个研究组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The rapid control of patients presenting to the emergency department (ED) with psychomotor agitation and violent behavior is paramount for the safety of patients and ED staff. The use of intramuscular (IM) ketamine in the pre-hospital and ED settings has demonstrated promising preliminary results to provide rapid and safe behavioral control. A prospective, randomized controlled trial is required to measure the potential superiority of IM ketamine compared to current standard care (IM benzodiazepines plus antipsychotics). METHODS: This will be a parallel, prospective, randomized, controlled trial of 5 mg/kg IM ketamine compared to a combination of 5 mg IM midazolam and 5 mg IM haloperidol. The study will enroll approximately 184 patients, randomized equally to two study arms. There will be one study visit during which study medication will be administered and assessments will be completed. A follow-up safety visit will occur on day 3. The primary objective of this study is to compare IM ketamine to a combination of IM midazolam and haloperidol with regards to the time required for adequate behavioral control, in minutes, in patients presenting to the ED with psychomotor agitation and violent behavior, as measured by the Richmond Agitation-Sedation Scale (RASS). DISCUSSION: We present a novel study to determine whether ketamine is a rapid and safe option, compared to a combination of midazolam and haloperidol for the sedation of patients presenting to the ED with psychomotor agitation and violent behavior. To our knowledge, this study is the first randomized controlled trial to compare ketamine to current standard care for this indication. We have attempted to address numerous logistical issues with the design of this study including a waiver of consent, ensuring adequate blinding of outcome assessors, patient enrolment, and data monitoring. TRIAL REGISTRATION: Clinicaltrials.gov, NCT03375671 . Registered on 18 December 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Barbic D, Andolfatto G, Grunau B, et al. Rapid agitation control with ketamine in the emergency department (RACKED): a randomized controlled trial protocol. Trials. 2018. PMID: 30477544. doi:10.1186/s13063-018-2992-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。